Kurarinone ameliorates intestinal mucosal inflammation via regulating T cell immunity
Our study investigated the impact of KAR on mice with TNBS-induced colitis and elucidated its underlying mechanisms, thereby uncovering novel possibilities for clinical interventions in IBD.
Authors
- Yan Pan (ORCID: https://orcid.org/0000-0003-3164-5939)
- Chong He (ORCID: https://orcid.org/0000-0002-0228-1833)
- Caiping Gao
- Zhou Zhou (ORCID: https://orcid.org/0000-0002-7175-8957)
- Tingting Wang (ORCID: https://orcid.org/0000-0003-4351-6480)
- Jinxia Wang (ORCID: https://orcid.org/0009-0002-9661-5749)
- Bolin Deng
Institutions
- University of Electronic Science and Technology of China (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.3389/fimmu.2025.1587479
- Citations
- 1
- Primary Topic
- Bioactive Compounds and Antitumor Agents
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- National Natural Science Foundation of China